This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Therapharm Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kim Orchard: Innovator in Immunoconjugate Therapy
Introduction
Kim Orchard is a prominent inventor based in Hampshire, GB. She has made significant contributions to the field of medical science, particularly in the treatment of haematological malignancies. Her innovative work focuses on the development of immunoconjugates, which are crucial for advancing cancer therapies.
Latest Patents
Kim Orchard holds a patent for an "Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies." This invention relates to the use of radioimmunoconjugates specifically designed for treating haematological malignancies, with a strong emphasis on multiple myeloma. Her patent represents a significant advancement in targeted cancer treatment.
Career Highlights
Kim Orchard is currently associated with Therapharm GmbH, where she continues to push the boundaries of medical innovation. Her work at the company has been instrumental in developing therapies that improve patient outcomes in the field of oncology.
Collaborations
Throughout her career, Kim has collaborated with notable professionals in her field, including Ivan Benes and Klaus Bosslet. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Kim Orchard's contributions to immunoconjugate therapy exemplify her dedication to advancing cancer treatment. Her innovative spirit and collaborative efforts continue to inspire progress in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile